209 related articles for article (PubMed ID: 7767507)
1. Clarifying the conundrum of conjunctive anticoagulation and coronary thrombolysis.
Sobel BE
Coron Artery Dis; 1995 Jan; 6(1):83-6. PubMed ID: 7767507
[No Abstract] [Full Text] [Related]
2. On "Current role of antithrombotic agents in the treatment of acute coronary syndromes" (Semin Thromb Hemost 2004;30:627-632).
Nessel CO
Semin Thromb Hemost; 2005 Apr; 31(2):248. PubMed ID: 15852228
[No Abstract] [Full Text] [Related]
3. Coronary thrombolysis: hemorrhagic complications.
Hirsh J
Can J Cardiol; 1993; 9(6):505-11. PubMed ID: 8221344
[No Abstract] [Full Text] [Related]
4. Aspirin after thrombolysis for MI.
Seaton TL
J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
[No Abstract] [Full Text] [Related]
5. Substitution of fractionated for unfractionated heparin during high-risk percutaneous coronary intervention: has the problem been solved?
Eisenberg MJ
J Am Coll Cardiol; 2007 Jun; 49(23):2247-8. PubMed ID: 17560288
[No Abstract] [Full Text] [Related]
6. Fatal cardiac rupture among patients treated with thrombolytic agents and adjunctive thrombin antagonists: observations from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction 9 Study.
Becker RC; Hochman JS; Cannon CP; Spencer FA; Ball SP; Rizzo MJ; Antman EM
J Am Coll Cardiol; 1999 Feb; 33(2):479-87. PubMed ID: 9973029
[TBL] [Abstract][Full Text] [Related]
7. [Anti thrombotic therapy after coronary thrombolysis].
Tani S; Kanmatsuse K
Nihon Rinsho; 2003 Apr; 61 Suppl 4():484-8. PubMed ID: 12735020
[No Abstract] [Full Text] [Related]
8. Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25).
Antman EM; Morrow DA; McCabe CH; Jiang F; White HD; Fox KA; Sharma D; Chew P; Braunwald E;
Am Heart J; 2005 Feb; 149(2):217-26. PubMed ID: 15846258
[No Abstract] [Full Text] [Related]
9. Intracranial hemorrhage after thrombolytic therapy. A perspective.
Simoons ML; de Jaegere P; van Domburg R; Boersma E
Z Kardiol; 1993; 82 Suppl 2():153-6. PubMed ID: 8328195
[TBL] [Abstract][Full Text] [Related]
10. Preoperative stop or continue? New antithrombotic and anticoagulants.
Ickx BE
Acta Anaesthesiol Belg; 2001; 52(4):385-93. PubMed ID: 11799571
[No Abstract] [Full Text] [Related]
11. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
12. [Anticoagulation in thrombolytic therapy: importance and future perspectives].
Harenberg J; Heene DL
Z Gesamte Inn Med; 1993; 48(6-7):283-8. PubMed ID: 8333224
[TBL] [Abstract][Full Text] [Related]
13. Coronary thrombolysis: adjuvant medical therapy.
Theroux P; Roy L
Can J Cardiol; 1993; 9(6):524-8. PubMed ID: 8221351
[No Abstract] [Full Text] [Related]
14. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
[TBL] [Abstract][Full Text] [Related]
15. Danger of treatment protocols.
Cucchiara B; Messé S; Kasner SE
Stroke; 2003 May; 34(5):e19. PubMed ID: 12690208
[No Abstract] [Full Text] [Related]
16. Thrombolysis in the management of acute myocardial infarction. Current status and future perspectives.
Verheugt F
Rev Port Cardiol; 1998 Dec; 17(12):959-65. PubMed ID: 9973856
[TBL] [Abstract][Full Text] [Related]
17. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
18. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage.
Sloan MA; Sila CA; Mahaffey KW; Granger CB; Longstreth WT; Koudstaal P; White HD; Gore JM; Simoons ML; Weaver WD; Green CL; Topol EJ; Califf RM
Circulation; 1998 Oct; 98(14):1376-82. PubMed ID: 9760291
[TBL] [Abstract][Full Text] [Related]
19. Stroke risk with higher heparin, hirudin dosages halts studies.
Am J Health Syst Pharm; 1995 Jan; 52(1):8, 10. PubMed ID: 12879517
[No Abstract] [Full Text] [Related]
20. The vulnerable endothelium: priming the vascular endothelium for thrombosis with unfractionated heparin: biologic plausibility for observations from the Superior Yield of the New Strategy of Enoxaparin, Revascularization and GlYcoprotein IIb/IIIa Inhibitors (SYNERGY) trial.
Becker RC
Am Heart J; 2005 Aug; 150(2):189-92. PubMed ID: 16086916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
